Pharma will usher in four obesity drugs in 2027 alone in billion-dollar expansion. Global obesity drug market is projected to hit $100 billion by 2030, analysts say. READ MORE: Weight loss drug in trials burns fat
Those who had trouble conceiving have lost weight, improving pregnancy odds. Any amount of weight loss improves hormone balance including estrogen levels. READ MORE: Forget weight loss, could Ozempic
A surprising thing is happening to some women on weight-loss drugs who’ve struggled with fertility issues: They’re getting pregnant.
A surprising thing is happening to some women on weight-loss drugs who’ve struggled with fertility issues: They’re getting pregnant.
A surprising thing is happening to some women on weight-loss drugs who’ve struggled with fertility issues: They’re getting pregnant.
A surprising thing is happening to some women on weight-loss drugs who’ve struggled with fertility issues: They’re getting pregnant.
Experts say rise in weight loss drugs popularity is also causing 'Ozempic face'. Below stars who the plastic surgeons say all show signs of the drug's side effect. READ MORE: Doctor warns Ozempic raises risk of pancreatic cancer
Ever since college, Brad Jobling struggled with his weight, fluctuating between a low of 155 pounds when he was in his thirties to as high as 220. He spent a decade tracking calories on WeightWatchers, but the pounds he dropped always crept back onto his 5-foot-5-inch frame. A little over a year ago, the 58-year-old Manhattan resident went on a new weight loss drug called Wegovy. He’s lost 30 pounds, and has started eating healthier food and exercising—the habits behind many commercial diet...
Zepbound, a drug that rivals Ozempic, may one day be a treatment for sleep apnea, according to results from a new study.
Finland has seen a surge in demand for popular anti-obesity medications.
A growing number of insurance carriers say they won't cover the cost of weight loss medications because it is too high. The change is forcing some patients to take desperate measures. NBC News' Erin McLaughlin reports.
The demand for appetite-repressing medications like Ozempic, Saxenda, and Wegovy is skyrocketing in the Netherlands, the Telegraaf reports based on figures from pharmaceuticals. The newspaper links the high demand to increasing obesity and weight issues in the country.